Cargando…

Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer

Although the tumor-stroma ratio (TSR) has prognostic value in many cancers, the traditional semi-quantitative visual assessment method has inter-observer variability, making it impossible for clinical practice. We aimed to develop a machine learning (ML) algorithm for accurately quantifying TSR in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qingyuan, Jiang, Zhengyu, Ni, Xinmiao, Yang, Song, Jiao, Panpan, Wu, Jiejun, Xiong, Lin, Yuan, Jingping, Wang, Jingsong, Jian, Jun, Wang, Lei, Yang, Rui, Chen, Zhiyuan, Liu, Xiuheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916896/
https://www.ncbi.nlm.nih.gov/pubmed/36769068
http://dx.doi.org/10.3390/ijms24032746
_version_ 1784886237765566464
author Zheng, Qingyuan
Jiang, Zhengyu
Ni, Xinmiao
Yang, Song
Jiao, Panpan
Wu, Jiejun
Xiong, Lin
Yuan, Jingping
Wang, Jingsong
Jian, Jun
Wang, Lei
Yang, Rui
Chen, Zhiyuan
Liu, Xiuheng
author_facet Zheng, Qingyuan
Jiang, Zhengyu
Ni, Xinmiao
Yang, Song
Jiao, Panpan
Wu, Jiejun
Xiong, Lin
Yuan, Jingping
Wang, Jingsong
Jian, Jun
Wang, Lei
Yang, Rui
Chen, Zhiyuan
Liu, Xiuheng
author_sort Zheng, Qingyuan
collection PubMed
description Although the tumor-stroma ratio (TSR) has prognostic value in many cancers, the traditional semi-quantitative visual assessment method has inter-observer variability, making it impossible for clinical practice. We aimed to develop a machine learning (ML) algorithm for accurately quantifying TSR in hematoxylin-and-eosin (H&E)-stained whole slide images (WSI) and further investigate its prognostic effect in patients with muscle-invasive bladder cancer (MIBC). We used an optimal cell classifier previously built based on QuPath open-source software and ML algorithm for quantitative calculation of TSR. We retrospectively analyzed data from two independent cohorts to verify the prognostic significance of ML-based TSR in MIBC patients. WSIs from 133 MIBC patients were used as the discovery set to identify the optimal association of TSR with patient survival outcomes. Furthermore, we performed validation in an independent external cohort consisting of 261 MIBC patients. We demonstrated a significant prognostic association of ML-based TSR with survival outcomes in MIBC patients (p < 0.001 for all comparisons), with higher TSR associated with better prognosis. Uni- and multivariate Cox regression analyses showed that TSR was independently associated with overall survival (p < 0.001 for all analyses) after adjusting for clinicopathological factors including age, gender, and pathologic stage. TSR was found to be a strong prognostic factor that was not redundant with the existing staging system in different subgroup analyses (p < 0.05 for all analyses). Finally, the expression of six genes (DACH1, DEEND2A, NOTCH4, DTWD1, TAF6L, and MARCHF5) were significantly associated with TSR, revealing possible potential biological relevance. In conclusion, we developed an ML algorithm based on WSIs of MIBC patients to accurately quantify TSR and demonstrated its prognostic validity for MIBC patients in two independent cohorts. This objective quantitative method allows application in clinical practice while reducing the workload of pathologists. Thus, it might be of significant aid in promoting precise pathology services in MIBC.
format Online
Article
Text
id pubmed-9916896
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99168962023-02-11 Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer Zheng, Qingyuan Jiang, Zhengyu Ni, Xinmiao Yang, Song Jiao, Panpan Wu, Jiejun Xiong, Lin Yuan, Jingping Wang, Jingsong Jian, Jun Wang, Lei Yang, Rui Chen, Zhiyuan Liu, Xiuheng Int J Mol Sci Article Although the tumor-stroma ratio (TSR) has prognostic value in many cancers, the traditional semi-quantitative visual assessment method has inter-observer variability, making it impossible for clinical practice. We aimed to develop a machine learning (ML) algorithm for accurately quantifying TSR in hematoxylin-and-eosin (H&E)-stained whole slide images (WSI) and further investigate its prognostic effect in patients with muscle-invasive bladder cancer (MIBC). We used an optimal cell classifier previously built based on QuPath open-source software and ML algorithm for quantitative calculation of TSR. We retrospectively analyzed data from two independent cohorts to verify the prognostic significance of ML-based TSR in MIBC patients. WSIs from 133 MIBC patients were used as the discovery set to identify the optimal association of TSR with patient survival outcomes. Furthermore, we performed validation in an independent external cohort consisting of 261 MIBC patients. We demonstrated a significant prognostic association of ML-based TSR with survival outcomes in MIBC patients (p < 0.001 for all comparisons), with higher TSR associated with better prognosis. Uni- and multivariate Cox regression analyses showed that TSR was independently associated with overall survival (p < 0.001 for all analyses) after adjusting for clinicopathological factors including age, gender, and pathologic stage. TSR was found to be a strong prognostic factor that was not redundant with the existing staging system in different subgroup analyses (p < 0.05 for all analyses). Finally, the expression of six genes (DACH1, DEEND2A, NOTCH4, DTWD1, TAF6L, and MARCHF5) were significantly associated with TSR, revealing possible potential biological relevance. In conclusion, we developed an ML algorithm based on WSIs of MIBC patients to accurately quantify TSR and demonstrated its prognostic validity for MIBC patients in two independent cohorts. This objective quantitative method allows application in clinical practice while reducing the workload of pathologists. Thus, it might be of significant aid in promoting precise pathology services in MIBC. MDPI 2023-02-01 /pmc/articles/PMC9916896/ /pubmed/36769068 http://dx.doi.org/10.3390/ijms24032746 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zheng, Qingyuan
Jiang, Zhengyu
Ni, Xinmiao
Yang, Song
Jiao, Panpan
Wu, Jiejun
Xiong, Lin
Yuan, Jingping
Wang, Jingsong
Jian, Jun
Wang, Lei
Yang, Rui
Chen, Zhiyuan
Liu, Xiuheng
Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
title Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
title_full Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
title_fullStr Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
title_full_unstemmed Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
title_short Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
title_sort machine learning quantified tumor-stroma ratio is an independent prognosticator in muscle-invasive bladder cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916896/
https://www.ncbi.nlm.nih.gov/pubmed/36769068
http://dx.doi.org/10.3390/ijms24032746
work_keys_str_mv AT zhengqingyuan machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT jiangzhengyu machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT nixinmiao machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT yangsong machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT jiaopanpan machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT wujiejun machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT xionglin machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT yuanjingping machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT wangjingsong machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT jianjun machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT wanglei machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT yangrui machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT chenzhiyuan machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer
AT liuxiuheng machinelearningquantifiedtumorstromaratioisanindependentprognosticatorinmuscleinvasivebladdercancer